This compound is a chiral pharmaceutical intermediate featuring a tetrahydrofuran ring substituted with a difluoromethoxyphenyl group and multiple fluorine atoms. Its stereochemistry is defined, making it suitable for use in the synthesis of enantiomerically pure active pharmaceutical ingredients.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2649470-87-9
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid (R)-1-phenylethan-1-amine salt
n.a
N-Carbobenzoxy-L-glutamine
protected amino acid intermediate
(2S)-1-methoxypropan-2-ol
Pharmaceutical intermediate for olmesartan medoxomil
3-amino-N-(4-aminophenyl)benzamide
pharmaceutical intermediate
Butanamide, N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-
Pharmaceutical intermediate for benzimidazolone synthesis
(3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate
active pharmaceutical ingredient
Suzetrigine Impurity 4
Pharmaceutical impurity reference standard
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-carboxylic acid
HMJBDIINGXHMMN-BEWJGFNTSA-N
C[C@H]1[C@H]([C@@H](O[C@@]1(C)C(F)(F)F)C(=O)O)C2=C(C(=C(C=C2)F)F)OC